Harvard Researchers Provide Guidance for Reviewers of RWE Studies

A recent article, published in Clinical Pharmacology and Therapeutics, highlights common pitfalls facing reviewers more familiar with reviewing randomized controlled trial studies rather than real world evidence (RWE) studies. Drs. Shirley Wang and Sebastian Schneeweiss of Harvard Medical School provide introductory guidance on effectively reviewing RWE studies.

“As RWE studies are increasingly considered for regulatory, coverage and other clinical decision-making, non-specialists will find themselves in the position of assessing the validity of RWE studies, a field that may be less familiar to them.” Read the article here.

(Source: Wang & Schneeweiss, Clinical Pharmacology and Therapeutics, 8/21)